Physical Description
White to off-white powder
Identification (IR)
To conform to standard
Identification (HPLC)
To conform to standard
Solubility (2.5% in 0.1M HCl)
Clear to slightly opalescent solution
Fluoroquinolonic acid
≤ 0.2%
Ciprofloxacin Ethylenediamine Analog
≤ 0.2%
Any Individual Unspecified Impurity
≤ 0.2%
Residue on Ignition
≤ 0.1%
Loss on Drying
≤ 1.0% (120°C, 6h)
Assay (HPLC)
98.0 - 102.0 % (dried basis)
Pharmacopoeia Specification(s)
USP
Specification Version
1.1
Not classified as a hazardous substance or mixture
If you are publishing research using GA9068 please contact us to contribute to our list of citations.
In vitro activity of gepotidacin against urine isolates of Escherichia coli from outpatient departments in Germany
Michael Kresken, Esther Wohlfarth, Chase Weikel, Deborah Butler, Yvonne Pfeifer, Guido Werner,
Journal of Antimicrobial Chemotherapy, 418–422, 78(2) (2023)
Escherichia coli is the leading pathogen of community-acquired urinary tract infections. Gepotidacin is a novel, bactericidal, first-in-class triazaacenaphthylene oral antibiotic that inhibits bacterial DNA replication by a distinct mechanism of action that confers activity against most strains of …
read more